ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,978Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 46

$629K Total Retail Price of All Prescriptions

Rank: 5 out of 46

517 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 517 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

17% of this provider’s 517 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

1% of this provider’s 9,700 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LISINOPRIL 661 584 1 3
AMLODIPINE BESYLATE 486 453 2 8
HYDROCODONE-ACETAMINOPHEN 436 258 S3 3 1
LEVOTHYROXINE SODIUM 386 341 4 4
LOVASTATIN 339 311 5 53
ATENOLOL 297 284 6 18
METFORMIN HCL 280 229 7 9
HYDROCHLOROTHIAZIDE 268 241 8 14
FUROSEMIDE 248 233 9 7
OMEPRAZOLE 237 201 10 5
SIMVASTATIN 233 204 11 6
GABAPENTIN 227 181 12 11
ATORVASTATIN CALCIUM 172 155 13 20
METOPROLOL SUCCINATE 172 132 13 17
METOPROLOL TARTRATE 171 158 15 10
ZOLPIDEM TARTRATE 168 130 16 21
CRESTOR 165 125 17 42
DONEPEZIL HCL 149 147 18 19
ALENDRONATE SODIUM 147 141 19 28
CARVEDILOL 133 106 20 29
POTASSIUM CHLORIDE 129 120 21 15
DIOVAN 117 109 22 77
MORPHINE SULFATE ER 111 65 S2 23 95
NAMENDA 110 109 24 24
TRAMADOL HCL 107 85 25 16
CLOPIDOGREL 103 90 26 48
SERTRALINE HCL 100 58 27 22
WARFARIN SODIUM 97 92 28 13
PRAVASTATIN SODIUM 97 85 28 12
GLIPIZIDE ER 93 86 30 106
PANTOPRAZOLE SODIUM 93 66 30 52
LANTUS 91 79 32 35
PLAVIX 87 79 33 75
PREDNISONE 80 64 34 51
CYMBALTA 80 43 34 32
POLYETHYLENE GLYCOL 3350 76 68 36 34
BENAZEPRIL HCL 72 66 37 76
LISINOPRIL-HYDROCHLOROTHIAZIDE 70 47 38 27
INSULIN SYRINGE 66 66 39 117
TAMSULOSIN HCL 65 57 40 25
FLUOXETINE HCL 64 31 41 50
ESCITALOPRAM OXALATE 64 49 41 49
SPIRIVA 64 46 41 68
HYDRALAZINE HCL 61 55 44 131
CARBIDOPA-LEVODOPA 60 54 45 90
ALLOPURINOL 56 44 46 40
AZITHROMYCIN 54 47 47 30
CIPROFLOXACIN HCL 52 51 48 46
LOSARTAN-HYDROCHLOROTHIAZIDE 52 52 48 73
RANITIDINE HCL 51 44 50 26
KLOR-CON M20 51 43 50 58
OXYBUTYNIN CHLORIDE 51 47 50 79
AMLODIPINE BESYLATE-BENAZEPRIL 51 41 50 107
DIGOXIN 51 44 50 80
LOSARTAN POTASSIUM 50 50 55 31
FLUTICASONE PROPIONATE 50 44 55 72
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 20, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.